{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:58:50Z","timestamp":1777687130379,"version":"3.51.4"},"reference-count":73,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,3,31]]},"DOI":"10.3233\/jhd-160189","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:15:13Z","timestamp":1459444513000},"page":"19-32","source":"Crossref","is-referenced-by-count":14,"title":["Delayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6\/2 Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1177","volume":"5","author":[{"given":"Elizabeth A.","family":"Skillings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-160189_ref1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.3233\/JHD-160189_ref2","unstructured":"Bates G , Harper P , Jones L . Huntington\u2019s disease. New York: Oxford University Press. 2002;3\u201327."},{"issue":"11","key":"10.3233\/JHD-160189_ref3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archneur.1992.00530350075022","article-title":"Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington\u2019s disease","volume":"49","author":"Grafton","year":"1992","journal-title":"Arch Neurol"},{"issue":"1","key":"10.3233\/JHD-160189_ref4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00870669","article-title":"Striatal glucose consumption in chorea-free subjects at risk of Huntington\u2019s disease","volume":"241","author":"Kuwert","year":"1993","journal-title":"J Neurol"},{"issue":"12","key":"10.3233\/JHD-160189_ref5","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.3233\/JHD-160189_ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: Selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"issue":"8","key":"10.3233\/JHD-160189_ref7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","article-title":"Body weight and dietary factors in Huntington\u2019s disease patients compared with matched controls","volume":"1","author":"Sanberg","year":"1981","journal-title":"Med J Aust"},{"issue":"1","key":"10.3233\/JHD-160189_ref8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","article-title":"Nutritional evaluation of Huntington disease patients","volume":"50","author":"Morales","year":"1989","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.3233\/JHD-160189_ref9","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-160189_ref10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"10.3233\/JHD-160189_ref11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.3233\/JHD-160189_ref12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-160189_ref13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(89)92143-0","article-title":"Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in ageing","volume":"1","author":"Trounce","year":"1989","journal-title":"Lancet"},{"key":"10.3233\/JHD-160189_ref14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0006-291X(89)92701-0","article-title":"Liver mitochondrial respiratory functions decline with age","volume":"165","author":"Yen","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.3233\/JHD-160189_ref15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann Neurol"},{"key":"10.3233\/JHD-160189_ref16","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"issue":"5","key":"10.3233\/JHD-160189_ref17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington\u2019s disease: Correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JHD-160189_ref18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesions of striatal neurons with kainic acid provides a model for Huntington\u2019s chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"issue":"5577","key":"10.3233\/JHD-160189_ref19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.3233\/JHD-160189_ref20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"issue":"7","key":"10.3233\/JHD-160189_ref21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: A model for Huntington\u2019s disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.3233\/JHD-160189_ref22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.3233\/JHD-160189_ref23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1566-2772(03)00054-9","article-title":"Excitotoxicity in Huntington disease","volume":"3","author":"Raymond","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"10.3233\/JHD-160189_ref24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mehy.2010.09.003","article-title":"Targeting glutamate mediated excitotoxicity in Huntington\u2019s disease: Neural progenitors and partial glutamate antagonist\u2014 memantine","volume":"76","author":"Anitha","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.3233\/JHD-160189_ref25","doi-asserted-by":"crossref","unstructured":"Fernandes HB , Raymond LA . NMDA receptors and Huntington\u2019s disease. Biology of the NMDA Receptor. CRC Press; 2009;Chapter 2.","DOI":"10.1201\/9781420044157.ch2"},{"key":"10.3233\/JHD-160189_ref26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(01)00323-2","article-title":"Neurotoxicity of glutamate uptake inhibition in vivo: Correlation with succinate dehydrogenase activity and prevention by energy substrates","volume":"106","author":"Massieu","year":"2001","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-160189_ref27","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.neuroscience.2007.03.024","article-title":"Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: Relation to energy imbalance or ATP depletion?","volume":"146","author":"Del Rio","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.3233\/JHD-160189_ref28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","article-title":"Mice transgenic for the human Huntington\u2019s disease mutation have reduced sensitivity to kainic acid toxicity","volume":"52","author":"Morton","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.3233\/JHD-160189_ref29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.33549\/physiolres.931049","article-title":"Integrative hypothesis for Huntington\u2019s disease: A brief review of experimental evidence","volume":"56","author":"P\u00e9rez-de la Cruz","year":"2007","journal-title":"Physiol Res"},{"key":"10.3233\/JHD-160189_ref30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post mortem brain from Huntington\u2019s disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.3233\/JHD-160189_ref31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JHD-160189_ref32","first-page":"1","article-title":"Dysfunctional mitochondrial respiration in the striatum of the Huntington\u2019s disease transgenic R6\/2 mouse model","author":"Aidt","year":"2013","journal-title":"PLoS Curr"},{"issue":"9","key":"10.3233\/JHD-160189_ref33","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","article-title":"3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase","volume":"74","author":"Alston","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.3233\/JHD-160189_ref34","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-160189_ref35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","article-title":"Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid","volume":"60","author":"Brouillet","year":"1993","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-160189_ref36","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-160189_ref37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","article-title":"Replicating Huntington\u2019s disease phenotype in experimental animals","volume":"59","author":"Brouillet","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.3233\/JHD-160189_ref38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","article-title":"3-Nitropropionic acid animal model and Huntington\u2019s disease","volume":"21","author":"Borlongan","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JHD-160189_ref39","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1046\/j.1471-4159.1998.71062642.x","article-title":"Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington\u2019s disease","volume":"71","author":"Bogdanov","year":"1998","journal-title":"J Neurochem"},{"issue":"5","key":"10.3233\/JHD-160189_ref40","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1046\/j.1471-4159.2000.0752163.x","article-title":"Mice transgenic for the Huntington\u2019s disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity","volume":"75","author":"Hickey","year":"2000","journal-title":"J Neurochem"},{"issue":"3","key":"10.3233\/JHD-160189_ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.shk.0000114828.98480.e0","article-title":"Preconditioning: Evolution of basic mechanisms to potential therapeutic strategies","volume":"21","author":"Tsai","year":"2004","journal-title":"Shock"},{"key":"10.3233\/JHD-160189_ref42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004311-196402000-00008","article-title":"Alterations in lysosomes (intracellular enzymes) during shock: Effects of preconditioning (tolerance) and protective drugs","volume":"2","author":"Janoff","year":"1964","journal-title":"Int Anesth Clin"},{"issue":"1","key":"10.3233\/JHD-160189_ref43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(96)12699-9","article-title":"Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor","volume":"211","author":"Riepe","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-160189_ref44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1006820927262","article-title":"Chemical preconditioning: A cytoprotective strategy","volume":"174","author":"Riepe","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/JHD-160189_ref45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0361-9230(02)00753-0","article-title":"Chemical preconditioning with 3-nitropropionic acid: Lack of induction of neuronal tolerance in gerbil hippocampus subjected to transient forebrain ischemia","volume":"1","author":"Garnier","year":"2002","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.3233\/JHD-160189_ref46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardiores.2005.12.012","article-title":"The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts","volume":"70","author":"Turan","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"17-18","key":"10.3233\/JHD-160189_ref47","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.lfs.2008.02.011","article-title":"Chemical preconditioning effect of 3-nitropropionic acid in anesthetized rat heart","volume":"82","author":"Turan","year":"2008","journal-title":"Life Sci"},{"key":"10.3233\/JHD-160189_ref48","first-page":"613","article-title":"The natural history of preconditioning: Cardioprotection depends on duration of transient ischemia and time to subsequent ischemia","volume":"2","author":"Van Winkle","year":"1991","journal-title":"Coron Artery Dis"},{"issue":"8","key":"10.3233\/JHD-160189_ref49","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0022-2828(95)90590-1","article-title":"Ischaemic preconditioning in a model of global ischaemia: Infarct size limitation, but no reduction of stunning","volume":"27","author":"Jenkins","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.3233\/JHD-160189_ref50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0008-6363(96)00026-0","article-title":"Infarct limitation of the second window of protection in conscious rabbit model","volume":"31","author":"Yang","year":"1996","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JHD-160189_ref51","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-160189_ref52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","article-title":"Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington\u2019s disease gene","volume":"15","author":"Carter","year":"2000","journal-title":"Mov Disord"},{"issue":"19","key":"10.3233\/JHD-160189_ref53","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddg249","article-title":"Complexin II is essential for normal neurological function in mice","volume":"12","author":"Glynn","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.3233\/JHD-160189_ref54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth1006-767","article-title":"Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system","volume":"3","author":"Morton","year":"2006","journal-title":"Nat Methods"},{"issue":"2","key":"10.3233\/JHD-160189_ref55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington\u2019s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp Brain Res"},{"issue":"4","key":"10.3233\/JHD-160189_ref56","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.e05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol Biol Cell"},{"issue":"23","key":"10.3233\/JHD-160189_ref57","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington\u2019s disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J Neurosci"},{"issue":"8","key":"10.3233\/JHD-160189_ref58","first-page":"2547","article-title":"Cardiac dysfunction in Huntington\u2019s disease","volume":"20","author":"Zielonka","year":"2014","journal-title":"Exp Clin Cardiol"},{"key":"10.3233\/JHD-160189_ref59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","article-title":"Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease","volume":"25","author":"Mihm","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-160189_ref60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JHD-2012-120004","article-title":"Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington\u2019s disease","volume":"1","author":"Wood","year":"2012","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"10.3233\/JHD-160189_ref61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JHD-130083","article-title":"Right ventricular dysfunction in the R6\/2 transgenic mouse model of Huntington\u2019s disease is unmasked by dobutamine","volume":"3","author":"Buonincontri","year":"2014","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-160189_ref62","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)62536-9","article-title":"Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice","volume":"159","author":"Gabrielson","year":"2001","journal-title":"Am J Pathol"},{"key":"10.3233\/JHD-160189_ref63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02828217","article-title":"Chemical preconditioning by 3-nitropropionic acid reduces ischemia-reperfusion injury in rat heart","volume":"25","author":"Hu","year":"2005","journal-title":"J Huazong Univ Sci Technolog Med Sci"},{"issue":"10","key":"10.3233\/JHD-160189_ref64","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s12272-001-2104-3","article-title":"The mechanism of the late preconditioning effect of 3-nitropropionic acid","volume":"31","author":"Basgut","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.3233\/JHD-160189_ref65","doi-asserted-by":"crossref","first-page":"e9077","DOI":"10.1371\/journal.pone.0009077","article-title":"Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington\u2019s disease","volume":"5","author":"Wood","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.3233\/JHD-160189_ref66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nbd.2011.02.005","article-title":"\u201cBrain training\u201d improves cognitive performance and survival in a transgenic mouse model of Huntington\u2019s disease","volume":"42","author":"Wood","year":"2011","journal-title":"Neurobiol. Dis"},{"issue":"4","key":"10.3233\/JHD-160189_ref67","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0168-0102(98)00010-8","article-title":"Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid","volume":"30","author":"Nishino","year":"1998","journal-title":"Neurosci Res"},{"issue":"1","key":"10.3233\/JHD-160189_ref68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(02)03488-1","article-title":"Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells","volume":"956","author":"Mogami","year":"2002","journal-title":"Brain Res"},{"issue":"6","key":"10.3233\/JHD-160189_ref69","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington\u2019s disease","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"23","key":"10.3233\/JHD-160189_ref70","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160189_ref71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.3233\/JHD-160189_ref72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.3233\/JHD-160189_ref73","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/WNL.45.12.2178","article-title":"Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid)","volume":"45","author":"He","year":"1995","journal-title":"Neurology"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-160189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:08Z","timestamp":1777453028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-160189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":73,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-160189","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}